stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Free cash flow
DENTSPLY SIRONA Inc.'s free cash flow for fiscal 2025 was $104.0M, down 63.0% from $281.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $272.0M. Over the past ten years it has ranged from $104.0M (fiscal 2025) to $562.0M (fiscal 2020) — the current reading is the lowest in ten years. DENTSPLY SIRONA Inc. ranks 13th of 51 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $104.0M | (62.99%) |
| FY2024 | $281.0M | 23.25% |
| FY2023 | $228.0M | (38.04%) |
| FY2022 | $368.0M | (28.54%) |
| FY2021 | $515.0M | (8.36%) |
| FY2020 | $562.0M | 8.91% |
| FY2019 | $516.0M | 60.75% |
| FY2018 | $321.0M | (29.96%) |
| FY2017 | $458.3M | 3.62% |
| FY2016 | $442.3M | 3.88% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $32.0M | (46.67%) |
| Jun 2026 | $60.0M | — |
| Mar 2026 | −$12.0M | — |
| Dec 2025 | $60.0M | 53.85% |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| XRAY DENTSPLY SIRONA Inc. | $272.0M |
| LMAT LeMaitre Vascular, Inc. compare | $67.0M |
| ATRC AtriCure, Inc. compare | $52.9M |
| WRBY Warby Parker Inc. compare | $21.3M |
| STAA STAAR Surgical Company compare | $17.8M |
| AZTA Azenta, Inc. compare | $9.9M |
| STVN Stevanato Group S.p.A. compare | −$8.8M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$123.1M |
| PLSE Pulse Biosciences, Inc compare | −$216.1M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement